Miltefosine

Miltefosine (also known as Impavido) is an anti-parasitic medication used to treat leishmaniasis, a parasitic infection that affects the skin and internal organs. It works by interfering with the formation of the cell wall of the parasite, causing it to die. Miltefosine is typically administered in oral form and may be used in combination with other medications, such as pentamidine or amphotericin B. Side effects may include nausea, vomiting, headache, and dizziness.

Miltefosine is a medication primarily used to treat a parasitic infection called leishmaniasis. Here's a breakdown of its key features:

Main Purpose:

• Treats leishmaniasis, a disease caused by Leishmania parasites transmitted by sandflies. It affects various body parts, causing skin sores, fever, and internal organ damage in severe cases.

How it Works:

• Miltefosine disrupts the cell membranes of Leishmania parasites, essentially killing them.
• The exact mechanism is still being studied, but it's believed to interfere with the parasite's ability to function and multiply.

Advantages:

• First-line oral treatment: Miltefosine is the only well-established oral medication for treating all three main forms of leishmaniasis: cutaneous (skin sores), visceral (internal organs), and mucosal (mucous membranes).
• Effectiveness: It offers high cure rates, particularly for visceral leishmaniasis, considered the most serious form.

Other Uses:

• Miltefosine is being investigated for its potential against other infections caused by free-living amoebas, such as Naegleria fowleri and Balamuthia mandrillaris.

Administration:

• Miltefosine is typically taken by mouth in capsule form.

Important Considerations:

• Miltefosine can cause side effects, including nausea, vomiting, abdominal pain, diarrhea, fever, and headache.
• It may not be suitable for everyone and can interact with other medications.
• Pregnancy and breastfeeding are contraindications, meaning it should not be used during.